Sera Prognostics prices $50M public offering of 1.25M shares and 11.25M pre-funded warrants

SERA PROGNOSTICS, INC.

Offering priced at $4.00 per share of Class A common stock and $3.9999 per pre-funded warrant.
Gross proceeds expected to be ~$50M before underwriting discounts and commissions.
Underwriters have 30-day option to purchase up to an additional 1.875M shares.
Proceeds to expand US commercial infrastructure, accelerate EU expansion, fund PreTRM studies and potential FDA submission.
Existing cash plus net proceeds expected to fund operations through 2028.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.